Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

Q: What does CUSIP 22053A107 represent in this 13F holders report?

CUSIP 22053A107 is the security identifier for QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value used to aggregate holder disclosures.

Q: How many institutions held QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in Q3 2023?

40 institutional investors reported QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 22053A107

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, par value $0.0001 par value
Shares outstanding: 55,541,178
Total 13F shares: 7,501,451
Share change: -1,473,181
Total reported value: $8,401,710
Put/Call ratio: 0%
Price per share: $1.12
Number of holders: 40
Value change: -$2,281,471
Number of buys: 12
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 22053A107?
CUSIP 22053A107 identifies QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) as of Q3 2023

As of 30 Sep 2023, Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,501,451 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, EPIQ Capital Group, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Alphabet Inc., BANK OF AMERICA CORP /DE/, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and TWO SIGMA ADVISERS, LP. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.